146 related articles for article (PubMed ID: 32072761)
1. Retrospective analysis of a Bi-National Colorectal Cancer Audit to characterize stage II colon cancer patients who were offered adjuvant chemotherapy.
Cooper EA; Buxey KN; Maslen BJ; Muhlmann M
ANZ J Surg; 2020 Jun; 90(6):1136-1140. PubMed ID: 32072761
[TBL] [Abstract][Full Text] [Related]
2. Colorectal multidisciplinary meeting audit to determine patient benefit.
Fernando C; Frizelle F; Wakeman C; Frampton C; Robinson B
ANZ J Surg; 2017 Nov; 87(11):E173-E177. PubMed ID: 26525919
[TBL] [Abstract][Full Text] [Related]
3. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
[No Abstract] [Full Text] [Related]
4. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
5. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
Gilbar P; Lee A; Pokharel K
J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
[TBL] [Abstract][Full Text] [Related]
6. [Effect of adjuvant chemotherapy on the prognosis of stage II( colon cancer patients with high risk factors].
Wu A; Chen P; Sun T; Wang X; Liu X; Yao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Dec; 20(12):1381-1386. PubMed ID: 29280121
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres.
Grant M; Haydon A; Au L; Wilkins S; Oliva K; Segelov E; Antill Y; Carne P; Ranchod P; Polglase A; Farmer C; Chin M; Wale R; Simpson P; Bell S; Skinner S; McMurrick P; Shapiro J
Int J Surg; 2018 Mar; 51():71-75. PubMed ID: 29367039
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
[TBL] [Abstract][Full Text] [Related]
9. A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.
Lindskog EB; Gunnarsdóttir KÁ; Derwinger K; Wettergren Y; Glimelius B; Kodeda K
BMC Cancer; 2014 Dec; 14():948. PubMed ID: 25495897
[TBL] [Abstract][Full Text] [Related]
10. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
[TBL] [Abstract][Full Text] [Related]
11. Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer.
Teufel A; Gerken M; Hartl J; Itzel T; Fichtner-Feigl S; Stroszczynski C; Schlitt HJ; Hofstädter F; Klinkhammer-Schalke M
BMC Cancer; 2015 May; 15():419. PubMed ID: 25985893
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
13. Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.
Lin CC; Lin JK; Chang SC; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC
Int J Colorectal Dis; 2009 Jun; 24(6):665-76. PubMed ID: 19238405
[TBL] [Abstract][Full Text] [Related]
14. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
Keikes L; Koopman M; Lemmens VEPP; VAN Oijen MGH; Punt CJA
Anticancer Res; 2020 Aug; 40(8):4331-4341. PubMed ID: 32727761
[TBL] [Abstract][Full Text] [Related]
15. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients.
Mahoney T; Kuo YH; Topilow A; Davis JM
Arch Surg; 2000 Feb; 135(2):182-5. PubMed ID: 10668878
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review.
Meyers BM; Cosby R; Quereshy F; Jonker D
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):459-465. PubMed ID: 28341242
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
Kim RH; Kavanaugh MM; Caldito GC
Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy].
Zhou ZG; Pan ZZ; Wan DS; Li LR; Wu XJ; Ding PR; Lin JZ; Peng ZH
Ai Zheng; 2009 Sep; 28(9):908-12. PubMed ID: 19728905
[TBL] [Abstract][Full Text] [Related]
20. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
